SOURCE: Kantar Health

Kantar Health

May 18, 2010 04:00 ET

Kantar Health Expands Treatment Value Practice Into Central and Eastern Europe

Kantar Health Names Dr. Pali Kolláth Regional Director, CEE and Treatment Value Practice

NEW YORK, NY--(Marketwire - May 18, 2010) -  Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, today announced the expansion of its Treatment Value Practice into Central and Eastern Europe (CEE) with the addition of Dr. Pali Kolláth as Regional Director, CEE and Treatment Value Practice. Dr. Kolláth is based in Budapest, Hungary.

"The CEE region represents a significant and growing portion of the global pharmaceutical market, and our customers view CEE as a region with an attractive growth potential," says Werner Guminski, CEO, Global Practice and Region Europe, for Kantar Health. "Furthermore, the CEE countries that have joined the European Union have a substantial impact on the 'old' EU from a market access perspective. Pali's presence in CEE will allow us to help our clients optimize market access and business performance in this fast-growing region."

In his new role, Dr. Kolláth will be responsible for directing strategic development for the Treatment Value Practice in CEE; building relationships with key decision-makers in the core countries of the region; and driving business development. He can be reached at pal.kollath@kantarhealth.com.

Dr. Kolláth has 18 years of pharmaceutical industry experience in which he served in various sales, marketing, business development and pricing and reimbursement roles at industry leaders such as Merck, Wyeth and Pfizer. He was most recently Director, CEE Regional Pricing and Market Access at Merck. Dr. Kolláth is a Veterinary Medical doctor with degrees from Hungary and the U.S., and he holds a Master of Business Administration degree from Edinburgh Business School in the UK.

About Kantar Health (www.kantarhealth.com)
Kantar Health is a leading healthcare-focused global consultancy, specializing in portfolio optimization, market access, safety and outcomes, and brand and customer insights. Formed by uniting Consumer Health Sciences, MattsonJack, TNS Healthcare and Ziment, it is the next-generation decision support partner to the pharmaceutical and biotech industries, delivering evidence-based guidance to support clients' global and local success.

With 40+ offices throughout the Americas, Europe, Asia-Pacific, the Middle East and Africa, Kantar Health provides the broadest global footprint, coupled with the strongest local knowledge to help drive clients' maximum performance in every geography. Market-leading solutions ensure optimal decisions and actions across the brand life cycle, from assessing opportunities and sizing markets... to developing products and building access strategies... to positioning brands and creating messaging... to managing stakeholder relationships and monitoring treatment outcomes.

Contact Information

  • Contact Information
    For more information on Kantar Health, please contact
    Paula Paradise
    Vice President of Global Marketing
    Email Contact
    +1-484-442-1431